ADHD and Anxiety: How to Tell Them Apart (and What to Do When You Have Both)

Both ADHD and anxiety can cause restlessness, difficulty concentrating, sleep problems, and irritability. At a symptom checklist level, they can look nearly identical — which is why people get misdiagnosed, or only half the picture gets treated.

The most useful clinical distinction is this: ADHD is a difficulty starting tasks (executive dysfunction — the brain can't initiate, sequence, or sustain effort), while anxiety is a difficulty stopping worry (the brain's threat-detection system is overactive and won't let go). The mechanism is different. The treatment is different. Getting this right matters enormously.

The inattentive presentation of ADHD — no outward hyperactivity, just difficulty with focus, memory, and follow-through — is especially easy to mistake for anxiety. The “freeze” many people experience when they can't start a task looks identical to the avoidance that comes from anxiety. From the outside, and often from the inside, it's the same behavior. The cause is different.

The numbers reflect the overlap: approximately 50% of adults with ADHD have a comorbid anxiety disorder. These are not separate populations — they are largely the same people, carrying both diagnoses, and often only being treated for one.

The table below captures the key clinical differences. These distinctions are not absolute — presentations vary — but they are useful anchors for understanding what's actually driving a given symptom.

When ADHD goes untreated, anxiety is often the result — not the cause. Missed deadlines, social missteps, forgotten commitments, and the accumulated weight of falling short of expectations create a chronic low-grade threat state. The brain learns that the world is unpredictable and that effort doesn't reliably produce results. That is fertile ground for anxiety.

This is why anxiety in people with ADHD is often described as a “downstream effect” — it is real anxiety, clinically significant, and deserving of treatment — but it is secondary to the ADHD that created the conditions for it. Treating only the anxiety without addressing the ADHD is treating a symptom while leaving the cause in place.

Rejection Sensitive Dysphoria (RSD)

RSD is an intense emotional pain triggered by perceived criticism, failure, or rejection that is neurologically tied to ADHD — not a separate anxiety disorder. The response can look like severe anxiety (avoidance, withdrawal, rumination) but the mechanism is different. Many people with ADHD and RSD have been treated for social anxiety for years without adequate improvement, because the underlying condition was never identified.

Masking in Women

Women with undiagnosed ADHD often develop anxious over-preparation and perfectionism as coping mechanisms. Triple-checking work, over-planning, arriving early to avoid any chance of disruption — these look like anxiety traits, and they often generate real anxiety. But the engine underneath is ADHD, not an anxiety disorder. The perfectionism is compensatory. Treating only the anxiety misses the reason the compensation was necessary.

Why Treating Only the Anxiety Often Fails

SSRIs and SNRIs can reduce the anxiety that is secondary to ADHD — but they do nothing for the executive dysfunction that is generating the anxiety in the first place. Partial improvement is common. Complete resolution is rare. When anxiety treatment produces only modest results, ADHD should always be on the differential.

The most important clinical move when ADHD and anxiety are both suspected is to assess for both simultaneously. Sequential diagnosis — treating the anxiety first, then reassessing — can delay the ADHD diagnosis by years. A clinician who only looks for one will only find one.

A good evaluation goes beyond a symptom checklist. It includes a full developmental history: How did you function as a child? In school? At work? In relationships? ADHD is a lifelong condition — evidence of a long-standing pattern is part of what makes the diagnosis valid.

Validated Questionnaires

• GAD-7 — a widely-used, validated 7-item scale for generalized anxiety disorder severity. Brief and reliable; gives your provider a quantified baseline.
• CAARS (Conners Adult ADHD Rating Scale) — validated for adults, assesses both inattentive and hyperactive-impulsive symptom dimensions.
• Conners — the broader Conners family of rating scales includes versions for adults and allows for self-report and observer-report comparison.

The Under-Diagnosis Pitfall

Here is a counterintuitive clinical reality: anxiety symptoms can actually suppress the outward hyperactivity of ADHD. A person with both conditions may appear calm, controlled, and anxiously compliant — and the ADHD never gets flagged. The anxiety is visible; the ADHD is masked by it. This is especially common in women and in adults who have developed sophisticated compensatory strategies.

For a full breakdown of what a good ADHD evaluation involves, including how to prepare for an appointment and what to ask your provider: See our guide to getting an ADHD evaluation as an adult →

There is no universal protocol for treating comorbid ADHD and anxiety — the right approach depends on which condition is more impairing, which has been present longer, and how they interact in a given person. What follows is a clinically grounded framework.

Stimulants First or SSRIs First?

This is a clinical decision made case by case. If ADHD is the more impairing condition and the anxiety appears secondary to it, treating ADHD first is often the right call. For many people, stimulants reduce anxiety by treating the ADHD that was causing it — the downstream anxiety resolves when the upstream dysfunction is addressed.

For others, stimulants worsen anxiety — particularly if the anxiety disorder is primary and independent. In those cases, non-stimulant ADHD medications are worth considering:

• Atomoxetine (Strattera) — a non-stimulant NRI approved for ADHD; some evidence for anxiety reduction as well.
• Viloxazine (Qelbree) — newer non-stimulant; selective NRI with some serotonergic activity.
• Bupropion (Wellbutrin) — off-label for ADHD; also an antidepressant. Does not typically worsen anxiety the way stimulants can.

Buspirone as an Adjunct

Buspirone is worth knowing about. It is an anxiolytic that works without the sedation of benzodiazepines and without the dependence risk. It is not a first-line treatment for anxiety, but it is useful as an adjunct — particularly in patients who need anxiety relief without the cognitive dulling that can come with higher SSRI doses.

CBT for Both Conditions

Cognitive Behavioral Therapy addresses both ADHD and anxiety — but the techniques differ. For anxiety: cognitive restructuring, worry scheduling, and graduated exposure. For ADHD: behavioral activation, executive function coaching, time management systems, and breaking the avoidance-shame cycle. A therapist experienced with both conditions can address them in parallel, rather than sequentially.

For a detailed guide to stimulants, non-stimulants, side effects, and titration, see the ADHD Medication for Adults guide.

If you think you might be dealing with both ADHD and anxiety, these five questions are specific enough to open a productive clinical conversation — even in a short appointment:

1. “I think I might have both ADHD and anxiety — can we assess for both at the same appointment?” — Puts both conditions on the table from the start, before the provider anchors on one diagnosis and stops looking.
2. “If I try a stimulant and my anxiety gets worse, what's the alternative?” — Establishes a contingency plan before starting. A good prescriber should have an answer ready. Non-stimulants are the next step.
3. “Is my anxiety possibly caused by untreated ADHD rather than a separate anxiety disorder?” — Raises the downstream anxiety hypothesis. Particularly relevant if you've tried anxiety treatment without full resolution.
4. “What does success look like if we're treating both? How will we know it's working?” — Asks for functional benchmarks, not just symptom scores. “We'll see how you feel” is not a sufficient answer.
5. “Can you explain how Rejection Sensitive Dysphoria is different from generalized anxiety?” — Tests whether your provider is familiar with RSD. If they are not, that is useful information about whether this is the right fit for your care.